首页> 外国专利> NEW CRYSTAL FORMS 4,4'- 4-FLUOR-7 ({4- 4- (3-fluorine-2-methylphenyl) butoxy phenyl} ethynyl) -2-methyl-1-1H-indol-1,3 -DIELE DIBUTANIC ACID, 4,4 '- 2-METHYL-7 - ({4- 4- (PENTAFLUOROPHENYL) BUTOXY Phenyl} Ethynyl) -1H-INDOL-1,3-DIYL DIBUTANIC ACID AND 4, 4 '- 4-Fluoro-2-methyl-7 - ({4- 4- (2,3,4,6-tetrafluorophenyl) butoxy phenyl} ethynyl) -1H-indole-1,3-diyl dibutane ACIDS

NEW CRYSTAL FORMS 4,4'- 4-FLUOR-7 ({4- 4- (3-fluorine-2-methylphenyl) butoxy phenyl} ethynyl) -2-methyl-1-1H-indol-1,3 -DIELE DIBUTANIC ACID, 4,4 '- 2-METHYL-7 - ({4- 4- (PENTAFLUOROPHENYL) BUTOXY Phenyl} Ethynyl) -1H-INDOL-1,3-DIYL DIBUTANIC ACID AND 4, 4 '- 4-Fluoro-2-methyl-7 - ({4- 4- (2,3,4,6-tetrafluorophenyl) butoxy phenyl} ethynyl) -1H-indole-1,3-diyl dibutane ACIDS

机译:新的晶体形式4,4'- [4-FLUOR-7({4- [4-(3-氟-2-甲基苯基)丁氧基]苯基}乙炔基)-2-甲基-1-1H-吲哚-1,3 -DIELE]丁二酸,4,4'-[2-甲基-7-({4- [4-(五氟苯基)丁基]苯基}乙炔基)-1H-INDOL-1,3-DIYL]丁二酸和4, 4'-[4-氟-2-甲基-7-({4- [4-(2,3,4,6-四氟苯基)丁氧基]苯基}乙炔基)-1H-吲哚-1,3-二基]二丁烷酸类

摘要

1. The crystalline form of 4,4 '- [4-fluoro-7 - ({4- [4- (3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl) -2-methyl-1H-indole-1,3 -diyl] dibutanoic acid having at least peaks in the X-ray powder diffraction spectrum at diffraction angles (2θ) of about 7.29, 10.24, 12.15, 17.95 and 18.44.2. Crystalline Form 4,4 '- [4-fluoro-7 - ({4- [4- (3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl) -2-methyl-1H-indole-1,3-diyl ] dibutanoic acid according to claim 1, having peaks at diffraction angles (2θ) of about 6.41, 7.29, 9.22, 10.03, 10.24, 12.15, 12.59, 13.36, 13.88, 14.15, 14.44, 16.60, 17.33, 17.95, 18.44, 18.86, 19.27, 20.23, 21.10, 21.85, 22, 26, 23.11, 23.63 and 24.38 in the powder X-ray diffraction spectrum. 3. Crystalline Form 4,4 '- [4-fluoro-7 - ({4- [4- (3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl) -2-methyl-1H-indole-1,3-diyl ] dibutanoic acid according to claim 2, characterized by a powder X-ray diffraction spectrum shown in FIG. 3.4. Crystalline Form 4,4 '- [4-fluoro-7 - ({4- [4- (3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl) -2-methyl-1H-indole-1,3-diyl ] dibutanoic acid having an endothermic peak at about 157 ° C in the spectrum obtained by differential scanning calorimetry. 5. Crystalline Form 4,4 '- [4-fluoro-7 - ({4- [4- (3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl) -2-methyl-1H-indole-1,3-diyl ] dibutanoic acid according to claim 4, characterized by a spectrum of differential scanning calorimetry shown in Fig.6.6. The crystalline form of 4,4 '- [2-methyl-7 - ({4- [4- (pentafluorophenyl) butoxy] phenyl} ethynyl) -1H-indole-1,3-diyl] dibutanoic acid having an X-ray diffraction spectrum on the powder, at least peaks at diffraction angles (2θ) of about 5.12, 10.16, 10.51, 14.90 and 20.42.7. The crystalline form of 4,4 '- [2-methyl-7 - ({4- [4- (pentafluorophenyl) butoxy] phenyl} ethynyl) -1H-indole-1,3-diyl] dibutanoic
机译:1. 4,4'-[4-氟-7-({4- [4-(3-氟-2-甲基苯基)丁氧基]苯基}乙炔基)-2-甲基-1H-吲哚-1的晶体形式在X射线粉末衍射光谱中至少在衍射角(2θ)为约7.29、10.24、12.15、17.95和18.4.2。处具有峰的1,3-二基]二丁酸。结晶形式4,4'-[4-氟-7-({4- [4-(3-氟-2-甲基苯基)丁氧基]苯基}乙炔基)-2-甲基-1H-吲哚-1,3-二基2.根据权利要求1的二丁酸,在衍射角(2θ)处具有约6.41、7.29、9.22、10.03、10.24、12.15、12.59、13.36、13.88、14.15、14.44、16.60、17.33、17.95、18.44、18.86,粉末X射线衍射光谱中的19.27、20.23、21.10、21.85、22、26、23.11、23.63和24.38。 3.结晶形式4,4'-[4-氟-7-({4- [4-(3-氟-2-甲基苯基)丁氧基]苯基}乙炔基)-2-甲基-1H-吲哚-1,3 3.根据权利要求2所述的[-二基]二丁酸,其特征在于,图1所示的粉末X射线衍射光谱为: 3.4。结晶形式4,4'-[4-氟-7-({4- [4-(3-氟-2-甲基苯基)丁氧基]苯基}乙炔基)-2-甲基-1H-吲哚-1,3-二基在通过差示扫描量热法获得的光谱中在约157℃具有吸热峰的二丁酸。 5.晶体形式4,4'-[4-氟-7-({4- [4-(3-氟-2-甲基苯基)丁氧基]苯基}乙炔基)-2-甲基-1H-吲哚-1,3 5.根据权利要求4所述的[-二基]二丁酸,其特征在于,差示扫描量热法的光谱如图6.6所示。具有X射线的4,4'-[2-甲基-7-({4- [4-(五氟苯基)丁氧基]苯基}乙炔基)-1H-吲哚-1,3-二基]二丁酸的结晶形式粉末上的衍射光谱,至少在约5.12、10.16、10.51、14.90和20.42.7的衍射角(2θ)处出现峰。 4,4'-[2-甲基-7-({4- [4-(五氟苯基)丁氧基]苯基}乙炔基)-1H-吲哚-1,3-二基]二丁酸的晶体形式

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号